Annual Meeting
Date: June 10, 2026
Time: 9:00 AM PT
Deadline to Register*: June 8, 2026 at 5pm PT
*Note: You must register by the deadline to be
eligible to participate in the meeting.
Our report on activities & financial performance throughout the year.
Information about our annual meeting & matters to be voted upon.
Request paper copies of the proxy materials online now, by email or by phone by dialing
866-648-8133.
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-230-8457.
Date: June 10, 2026
Time: 9:00 AM PT
Deadline to Register*: June 8, 2026 at 5pm PT
*Note: You must register by the deadline to be
eligible to participate in the meeting.
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with these rare diseases.